Reductions in overactive bladder-related incontinence from pooled analysis of phase III trials evaluating treatment with solifenacin
Authors:
- 20 April 2006
- journal article
- research article
- Published by Springer Nature in International Urogynecology Journal
- Vol. 17 (5) , 512-519
Abstract
The embarrassment and social stigma associated with urinary incontinence (UI) in overactive bladder syndrome (OAB) sufferers is a major reason for individuals to seek help for their condition. An analysis of 1,873 subjects with OAB with UI was conducted to assess the efficacy of solifenacin in reducing incontinence in a pooled population from four phase III clinical trials, stratified by severity of incontinence, urgency, and other key factors at baseline. Subjects were randomized to either 5 or 10 mg of solifenacin once daily or placebo for 12 weeks. More than 50% of the total population became continent at study end, with either dose of solifenacin (P<0.01 vs placebo). Significant reductions in incontinence episodes and higher rates of attainment of continence vs placebo were observed irrespective of age or severity of incontinence or urgency at baseline with solifenacin treatment. Treatment was well tolerated, with the majority of adverse events being mild in nature. Solifenacin is an effective antimuscarinic agent for the treatment of incontinence associated with OAB.Keywords
This publication has 12 references indexed in Scilit:
- The Impact of Urinary Urgency and Frequency on Health-Related Quality of Life in Overactive Bladder: Results from a National Community SurveyValue in Health, 2004
- Costs of urinary incontinence and overactive bladder in the United States: a comparative studyUrology, 2004
- Randomized, double‐blind placebo‐ and tolterodine‐controlled trial of the once‐daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladderBJU International, 2004
- The impact on health‐related quality of life of stress, urge and mixed urinary incontinenceBJU International, 2003
- Prevalence and burden of overactive bladder in the United StatesWorld Journal of Urology, 2003
- The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence SocietyUrology, 2003
- Geriatric considerations in the diagnosis and management of overactive bladderUrology, 2002
- How widespread are the symptoms of an overactive bladder and how are they managed? A population‐based prevalence studyBJU International, 2001
- The prevalence of overactive bladder.2000
- Economic considerations and outcome measurement in urge incontinenceUrology, 1997